Empresa NeuroOne Medical Technologies Corporation Other OTC
Acciones
NMTC
US64130M1009
Equipo médico y tecnología avanzada
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Strip/Grid Products, Stereoelectrocencephalography Products and Electrode Cable Assembly Products
57,3
%
| 0 | 8,1 % | 2 | 57,3 % | +1.040,65 % |
Collaborations
42,7
%
| 2 | 91,9 % | 1 | 42,7 % | -25,33 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +60,73 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 20/08/09 |
David Rosa
CEO | Chief Executive Officer | 59 | 20/07/17 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 01/01/21 |
Chief Operating Officer | 53 | 10/11 | |
Steven Mertens
CTO | Chief Tech/Sci/R&D Officer | 61 | 15/04/19 |
Chad Wilhelmy
LAW | General Counsel | - | 18/01/22 |
Hijaz Haris
SAM | Sales & Marketing | - | 27/04/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 04/08/17 |
Director/Board Member | 62 | 04/08/17 | |
Edward Andrle
BRD | Director/Board Member | 66 | 18/02/20 |
David Rosa
CEO | Chief Executive Officer | 59 | 20/07/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 27 515 921 | 24 384 092 ( 88,62 %) | 0 | 88,62 % |
Información de la empresa
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
-49,36 % | 2499,39 M | |
+26,27 % | 1996,59 M | |
-9,47 % | 1506,89 M | |
+26,55 % | 1327,9 M | |
-16,57 % | 960 M | |
-0,22 % | 802 M | |
-30,63 % | 793 M | |
-23,61 % | 640 M | |
+18,40 % | 577 M |